Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune DiseasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82024-05-280OAAI
Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-correctorJOURNAL OF MEDICINAL CHEMISTRYIF6.82024-03-250OAAI
The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosisEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92019-11-0111PREAI
2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosisEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92014-04-0121PREAI
1,2,3,4,8,9,10,11-Octahydrobenzo[j]phenanthridine-7,12-diones as New Leads against Mycobacterium tuberculosisJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-03-2142PREAI
Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholineEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92013-09-0136PREAI
Palladium(II)-Catalyzed Synthesis of 2H,3′H-Spiro[benzofuran-3,2′-naphthoquinones]JOURNAL OF ORGANIC CHEMISTRYIF3.62013-08-149PRE